Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population : Clinical Chemical Laboratory Medicine Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population

Ralph Green1 / Joshua W. Miller2

1.

2.

Corresponding author: Ralph Green, MD, UC Davis Medical Center, Department of Medical Pathology and Laboratory Medicine, PATH Building – Room 1106, 4400 V Street, Sacramento, CA 95817, USA Phone: +1 916-734-3330, Fax: +1 916-734-2652,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 43, Issue 10, Pages 1048–1051, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2005.183, October 2005

Abstract

Prevalence rates for folate deficiency and hyperhomocysteinemia have been markedly reduced following the introduction of folic acid fortification in the United States. We report the prevalence of hyperhomocysteinemia in a population of community-dwelling elderly Latinos in the post-folic acid fortification era. We measured homocysteine, total vitamin B12, holotranscobalamin, red blood cell folate, and serum creatinine in 1096 subjects aged ≥60 years. Hyperhomocysteinemia (>13 μmol/L) was observed in 16.5% of the subjects. The population attributable risk percentages for hyperhomocysteinemia were 29.7% for total B12 <148 pmol/L, 36.4% for holotranscobalamin <35 pmol/L, and 41.4% for creatinine >115 μmol/L. In contrast, the population attributable risk percentage for hyperhomocysteinemia was only 0.3% for red blood cell folate <365 nmol/L. We conclude that in the post-folic acid fortification era, low vitamin B12 status has become the dominant nutritional determinant of hyperhomocysteinemia. Steps to either reduce the prevalence of vitamin B12 deficiency or to identify and treat individuals with vitamin B12 deficiency could further reduce the prevalence of hyperhomocysteinemia.

Keywords: folate; fortification; homocysteine; transcobalamin; vitamin B12; PAR%, population attributable risk percentage; SALSA, Sacramento Area Latino Study on Aging

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Regan L. Bailey and Janneke P. van Wijngaarden
Current Osteoporosis Reports, 2015
[2]
Roman Pawlak
American Journal of Preventive Medicine, 2015, Volume 48, Number 6, Page e11
[3]
M M Boancă, H A Colosi, and E C Crăciun
European Journal of Clinical Nutrition, 2014, Volume 68, Number 2, Page 184
[4]
Gwenaëlle Douaud, Helga Refsum, Celeste A. de Jager, Robin Jacoby, Thomas E. Nichols, Stephen M. Smith, and A. David Smith
Proceedings of the National Academy of Sciences, 2013, Volume 110, Number 23, Page 9523
[5]
Paula Manuela de Castro Cardoso Pereira and Ana Filipa dos Reis Baltazar Vicente
Meat Science, 2013, Volume 93, Number 3, Page 586
[6]
David P. Steensma and Ayalew Tefferi
Mayo Clinic Proceedings, 2007, Volume 82, Number 8, Page 958
[7]
Deepali P. Sundrani, Preeti M. Chavan Gautam, Savita S. Mehendale, and Sadhana R. Joshi
Medical Hypotheses, 2011, Volume 77, Number 5, Page 878
[8]
Edward S. Moreira, Nicola E. Brasch, and June Yun
Free Radical Biology and Medicine, 2011, Volume 51, Number 4, Page 876
[9]
Donald R. Duerksen, Glen Fallows, and Charles N. Bernstein
Nutrition, 2006, Volume 22, Number 11-12, Page 1210
[10]
Cameron D. Willis, Adam G. Elshaug, Joanne L. Milverton, Amber M. Watt, Michael P. Metz, and Janet E. Hiller
Pathology, 2011, Volume 43, Number 5, Page 472
[11]
S.N. Wickramasinghe
Blood Reviews, 2006, Volume 20, Number 6, Page 299
[12]
Yeşim Özkan, Sevgi Yardım-Akaydın, Aylin Sepici, Başak Engin, Vesile Sepici, and Bolkan Şimşek
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 1
[13]
M G Garrod, L H Allen, M N Haan, R Green, and J W Miller
European Journal of Clinical Nutrition, 2010, Volume 64, Number 5, Page 503
[14]
Concepción Sánchez-Moreno, Antonio Jiménez-Escrig, and Antonio Martín
Nutrition Research Reviews, 2009, Volume 22, Number 01, Page 49
[15]
A. M. Matteini, J. D. Walston, M. D. Fallin, K. Bandeen-Roche, W. H. L. Kao, R. D. Semba, R. H. Allen, J. Guralnik, L. P. Fried, and S. P. Stabler
The Journal of Nutrition Health and Aging, 2008, Volume 12, Number 5, Page 303
[16]
Joel G. Ray, Philip R. Wyatt, Miles D. Thompson, Marian J. Vermeulen, Chris Meier, Pui-Yuen Wong, Sandra A. Farrell, and David E. C. Cole
Epidemiology, 2007, Volume 18, Number 3, Page 362
[17]
F D Couto, L M O Moreira, D B dos Santos, M G Reis, and M S Gonçalves
European Journal of Clinical Nutrition, 2007, Volume 61, Number 3, Page 382

Comments (0)

Please log in or register to comment.